Status of Legal Challenges to HHS Title X Family Planning Rule as of July 2, 2019
Map detailing the status of litigation surrounding the new HHS Title X family planning rules, as of July 2, 2019.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →
Map detailing the status of litigation surrounding the new HHS Title X family planning rules, as of July 2, 2019.
This week, the Trump administration proposed new rules around abortion coverage in the ACA Marketplace plans. Here’s how state policies shaping access to abortion coverage in Medicaid and private insurance have changed before and after the passage of the health law.
The day after the midterm elections, the Trump Administration moved forward with anticipated regulatory changes governing employer exemption from the Affordable Care Act’s (ACA) contraceptive coverage mandate based on religious or moral objections.
The Supreme Court's ruling in Medina v. Planned Parenthood of the South Atlantic means that Medicaid enrollees in South Carolina, and in other states that exclude Planned Parenthood going forward, will not be able to use their Medicaid coverage to obtain any preventive services, such as contraceptive care, STI treatment and cancer screenings, at Planned Parenthood clinics.
KFF recently updated its interactive dashboard with national and state data on women’s health, as well as information about various policies that affect women’s health.
According to an analysis of responses to KFF’s Employer Health Benefits Survey in 2023, relatively few (8%) large firms (with 200 or more workers) offering health benefits report reducing or expanding coverage for abortion since the U.S. Supreme Court overturned Roe v. Wade with the Dobbs v. Jackson ruling.
About 1 in 8 voters (12%) now say that abortion is the most important issue for their vote in the 2024 elections, highlighting how the issue could motivate groups of voters who largely say abortion should be legal in all or most cases, a new KFF Health Tracking Poll finds.
In advance of oral arguments about access to medication abortion before the Supreme Court on March 26, KFF examines how a Court ruling for the plaintiffs would limit access to mifepristone blocking its use in telehealth and distribution through pharmacies, including in states where abortion is legal and protected.
False claims about the safety of mifepristone are driving legislative and investigative action in Congress, even as major medical organizations and decades of clinical evidence support the drug’s safety. And competing interpretations of what censorship and free speech mean are impacting how health misinformation is moderated.
This issue brief provides a summary of the major policies and statutory requirements governing U.S. participation in international family planning and reproductive health efforts. These laws and policies collectively direct how funds are spent, which organizations receive funds and generally shape U.S. family planning and reproductive health activities around the world.
© 2026 KFF
